One of the stocks to have made a remarkably strong move over the course of the past week is the Regen Biopharma (OTCMKTS:RGBP) stock. The bullish trend in the stock continued on Thursday as investors continued to flock to the stock and sent it soaring by 29%.
Yesterday’s rally in the stock took its gains over the course of the past week to as much as 55%. The rally in the stock had actually started last Friday after the company published the transcript of a management discussion and since then the stock has continued to display strong momentum.
It might be a good move for investors to perhaps take a look at some of the highlights from the transcript. At the end of September 20, 2020, Regen Biopharma recorded account receivable of as much as $103192 and the figure for the same overhead stood at $130607 at the end of December 31, 2020.
In this context, it is important to point out that the boost to the amount of account receivables in December was brought about by the royalties and anniversary fees that had been paid to Regen by Zander. Investors could consider taking a look at the full transcript if they are interested.
